U.S. Physical Therapy’s (USPH) Outperform Rating Reaffirmed at Barrington Research

Barrington Research reaffirmed their outperform rating on shares of U.S. Physical Therapy (NYSE:USPHFree Report) in a research report report published on Tuesday,Benzinga reports. Barrington Research currently has a $98.00 price target on the stock.

Other analysts have also recently issued research reports about the stock. Wall Street Zen raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Thursday, May 8th. JMP Securities reissued a “market outperform” rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Finally, JPMorgan Chase & Co. cut their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, March 19th. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average price target of $109.00.

Read Our Latest Report on U.S. Physical Therapy

U.S. Physical Therapy Trading Up 3.6%

NYSE USPH opened at $81.04 on Tuesday. The firm has a 50 day simple moving average of $75.39 and a 200-day simple moving average of $79.76. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. U.S. Physical Therapy has a one year low of $62.77 and a one year high of $101.20. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of 37.17, a PEG ratio of 3.79 and a beta of 1.44.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The business had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. During the same quarter last year, the firm posted $0.51 earnings per share. The business’s revenue for the quarter was up 18.0% compared to the same quarter last year. Equities research analysts anticipate that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were given a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.22%. The ex-dividend date was Friday, May 23rd. U.S. Physical Therapy’s dividend payout ratio (DPR) is 82.57%.

Insider Transactions at U.S. Physical Therapy

In other news, Director Nancy Ham sold 400 shares of the stock in a transaction that occurred on Thursday, June 12th. The stock was sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares in the company, valued at approximately $202,357.94. This represents a 13.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of hedge funds have recently added to or reduced their stakes in the stock. HighTower Advisors LLC lifted its stake in U.S. Physical Therapy by 2.5% in the fourth quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock valued at $429,000 after buying an additional 119 shares during the last quarter. CBIZ Investment Advisory Services LLC increased its holdings in shares of U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares during the period. Portside Wealth Group LLC increased its holdings in shares of U.S. Physical Therapy by 3.9% during the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company’s stock valued at $297,000 after purchasing an additional 154 shares during the period. Precision Wealth Strategies LLC increased its holdings in shares of U.S. Physical Therapy by 6.6% during the first quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company’s stock valued at $221,000 after purchasing an additional 189 shares during the period. Finally, Aquatic Capital Management LLC increased its holdings in shares of U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock valued at $115,000 after purchasing an additional 198 shares during the period.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Articles

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.